11 May, 2009 – 20:04 | 7 Comments

In an about-face to their stance during the Clinton Administration, leaders of the nation’s healthcare industry have promised to cut prices in response to the Obama Administration’s vow to resolve the healthcare crisis and make health care available to every…

Read the full story »
Diet

Drugs

Lifestyle

Medical Research

Prevention

Home » Archive by Category

Articles in Bipolar Disorder

Is Financial Fraud Behind Dramatic Spike in Pediatric Antipsychotics?
29 November, 2008 – 7:23 | One Comment

The families of many children injured or sickened by the antipsychotic drugs they’d been prescribed are calling for the testimony of a prominent child psychiatrist whose endorsement of such drugs led to a 40-fold (4,000%) increase in diagnoses of pediatric…

The Virginia Tech Massacre Revisited
8 May, 2008 – 15:19 | No Comment

On April 16, 2007 23-year-old Seung-Hui Cho, a student at Virginia Tech University in Blacksburg, Virginia, USA, shot to death 32 students and faculty members, wounded many more, and then committed suicide. From an early age Cho was seen to…

Researchers Remain Undecided About Omega-3s Effects On Bipolar Disorder
29 April, 2008 – 7:25 | One Comment

Although there is significant clinical evidence to support using omega-3 fatty acid supplements for the treatment of depression symptoms, the supplement’s role in treating bipolar disorder is still undecided. Researchers do believe, however, that further studies should be conducted since…

Could Schizophrenia Be Entirely Genetic?
29 March, 2008 – 9:11 | 59 Comments

The latest gene-scanning technology may have shed some much-desired light on a potential cause for schizophrenia, a mental disorder characterized by delusions and scrambled thought processes. The disease is believed to affect 1% of the population.

Common Schizophrenia Drug on Trial
8 March, 2008 – 16:31 | 9 Comments

The pharmaceutical giant, Eli Lilly, is being sued by the state of Alaska over allegedly covering up the potential risks of Zyprexa (olanzapine). Attorneys for the state argue that the company knew that the drug, approved for the treatment of…

ABILIFY Now Available for Younger Patients with Bipolar Disorder
3 March, 2008 – 21:35 | One Comment

Otsuka Pharmaceutical Co., Ltd and Bristol-Myers Squibb Company have announced that a new drug for treatment of bipolar disorder in children and adolescents is now available. ABILIFY (aripiprazole) has been approved by the FDA for patients 10 to 17 years…